# Xos, Inc.: overview XOS · Nasdaq · CIK 1819493 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/xos.md) · [Financials](/companies/xos/financials.md) · [Filings](/companies/xos/filings.md) · [Insiders](/companies/xos/insiders.md) Latest reported revenue: [$4.7m](/filings/0001819493-26-000054.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001819493-26-000054). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [15.8](/filings/0001819493-25-000169.md) | [11.5 d](/filings/0001819493-26-000012.md) | [5.9](/filings/0001819493-26-000044.md) | [18.4](/filings/0001819493-26-000054.md) | [16.5](/filings/0001819493-25-000169.md) | [5.2 d](/filings/0001819493-26-000012.md) | [11.2](/filings/0001819493-26-000044.md) | [4.7](/filings/0001819493-26-000054.md) | | Gross margin | % | [18.1%](/filings/0001819493-25-000169.md) | [(32.4%) d](/filings/0001819493-26-000012.md) | [20.6%](/filings/0001819493-26-000044.md) | [8.9%](/filings/0001819493-26-000054.md) | [15.3%](/filings/0001819493-25-000169.md) | [(50.5%) d](/filings/0001819493-26-000012.md) | [38.6%](/filings/0001819493-26-000044.md) | [12.1%](/filings/0001819493-26-000054.md) | | Operating margin | % | [(61.4%)](/filings/0001819493-25-000169.md) | [(127.0%) d](/filings/0001819493-26-000012.md) | [(157.7%)](/filings/0001819493-26-000044.md) | [(38.4%)](/filings/0001819493-26-000054.md) | [(42.4%)](/filings/0001819493-25-000169.md) | [(186.6%) d](/filings/0001819493-26-000012.md) | [(41.7%)](/filings/0001819493-26-000044.md) | [(167.7%)](/filings/0001819493-26-000054.md) | | Net margin | % | [(66.6%)](/filings/0001819493-25-000169.md) | [(165.4%) d](/filings/0001819493-26-000012.md) | [(172.8%)](/filings/0001819493-26-000054.md) | [(40.7%)](/filings/0001819493-26-000054.md) | [12.9%](/filings/0001819493-25-000169.md) | [(186.8%) d](/filings/0001819493-26-000012.md) | [(43.8%)](/filings/0001819493-26-000054.md) | [(145.4%)](/filings/0001819493-26-000054.md) | | Diluted EPS | $ per share | [(1.32)](/filings/0001819493-25-000169.md) | not reported | [(1.26)](/filings/0001819493-26-000044.md) | [(0.90)](/filings/0001819493-26-000054.md) | [0.22](/filings/0001819493-25-000169.md) | not reported | [(0.43)](/filings/0001819493-26-000044.md) | [(0.55)](/filings/0001819493-26-000054.md) | | Free cash flow | $m | [(11.7) d](/filings/0001819493-25-000169.md) | [3.3 d](/filings/0001819493-26-000012.md) | [(4.8)](/filings/0001819493-26-000044.md) | [4.6 d](/filings/0001819493-26-000054.md) | [3.1 d](/filings/0001819493-25-000169.md) | [2.4 d](/filings/0001819493-26-000044.md) | [(1.6)](/filings/0001819493-26-000044.md) | [(2.7) d](/filings/0001819493-26-000054.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [5.0](/filings/0001819493-23-000066.md) | [36.4](/filings/0001819493-24-000050.md) | [44.5](/filings/0001819493-25-000043.md) | [56.0](/filings/0001819493-26-000012.md) | [46.0](/filings/0001819493-26-000012.md) | | Gross margin | % | [(46.8%)](/filings/0001819493-23-000066.md) | [(82.6%)](/filings/0001819493-24-000050.md) | [(2.9%)](/filings/0001819493-25-000043.md) | [7.1%](/filings/0001819493-26-000012.md) | [5.9%](/filings/0001819493-26-000012.md) | | Operating margin | % | [(1053.0%)](/filings/0001819493-23-000066.md) | [(306.1%)](/filings/0001819493-24-000050.md) | [(145.9%)](/filings/0001819493-25-000043.md) | [(82.0%)](/filings/0001819493-26-000012.md) | [(71.9%)](/filings/0001819493-26-000012.md) | | Net margin | % | [463.6%](/filings/0001819493-23-000066.md) | [(201.6%)](/filings/0001819493-24-000050.md) | [(170.3%)](/filings/0001819493-25-000043.md) | [(89.6%)](/filings/0001819493-26-000012.md) | [(55.1%)](/filings/0001819493-26-000012.md) | | Diluted EPS | $ per share | [0.22](/filings/0001819493-23-000066.md) | [(13.32)](/filings/0001819493-24-000050.md) | [(13.11)](/filings/0001819493-25-000043.md) | [(6.69)](/filings/0001819493-26-000012.md) | [(2.71)](/filings/0001819493-26-000012.md) | | Free cash flow | $m | [(93.8)](/filings/0001819493-23-000066.md) | [(142)](/filings/0001819493-24-000050.md) | [(40.7)](/filings/0001819493-25-000043.md) | [(49.1)](/filings/0001819493-26-000012.md) | [5.4](/filings/0001819493-26-000044.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/xos/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $673.6k | 223,039 | | Added +74,344 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $262.2k | 86,802 | | Reduced −10,607 | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $241.5k | 79,979 | | New +79,979 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $233.9k | 77,453 | | New +77,453 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $151.3k | 50,085 | | Added +23,845 | | [ALGERT GLOBAL LLC](/funds/1275218.md) | 2026-06-30 | $137.9k | 45,663 | | New +45,663 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $91.6k | 30,347 | | Added +30,298 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $62.0k | 20,527 | | New +20,527 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $51.8k | 17,162 | | Added +17,159 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $44.0k | 14,527 | | Reduced −146 | ## Recent filings [All 728 filings](/companies/xos/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 20:17 ET | [8-K](/filings/0001819493-26-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819493-26-000055 | | 2026-08-13 | 20:14 ET | [10-Q](/filings/0001819493-26-000054.md) | Quarterly report, period 2026-06-30 | 0001819493-26-000054 | | 2026-06-25 | 20:44 ET | [8-K](/filings/0001819493-26-000047.md) | 5.07 Shareholder vote results | 0001819493-26-000047 | | 2026-06-22 | 21:21 ET | [SCHEDULE 13D/A](/filings/0001879464-26-000011.md) | Ownership report, active investor, amended | 0001879464-26-000011 | | 2026-06-05 | 21:09 ET | [8-K](/filings/0001213900-26-065896.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-065896 | | 2026-05-14 | 20:17 ET | [10-Q](/filings/0001819493-26-000044.md) | Quarterly report, period 2026-03-31 | 0001819493-26-000044 | | 2026-05-14 | 20:15 ET | [8-K](/filings/0001819493-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001819493-26-000043 | | 2026-05-13 | 21:08 ET | [SCHEDULE 13D/A](/filings/0001878366-26-000024.md) | Ownership report, active investor, amended | 0001878366-26-000024 | | 2026-05-13 | 21:01 ET | [8-K](/filings/0001819493-26-000034.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001819493-26-000034 | | 2026-05-08 | 21:25 ET | [SCHEDULE 13D/A](/filings/0001878366-26-000013.md) | Ownership report, active investor, amended | 0001878366-26-000013 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001819493-26-000008.md), filed Mar 30, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/2cf05f5b-ebc3-48a3-9049-118cc1149278) ## About the filer - CIK: 1819493 - Tickers: XOS - Exchange: Nasdaq - SIC code: 3714 Motor Vehicle Parts & Accessories - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.